Letter to Editor: Reply to R.T. Casey (Semin Oncol. 2018 Jun;45(3):151-155)

Semin Oncol. 2019 Feb;46(1):104-105. doi: 10.1053/j.seminoncol.2018.12.005. Epub 2019 Jan 2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adrenocortical Carcinoma*
  • Antibodies, Monoclonal, Humanized
  • DNA Mismatch Repair
  • Disease Progression
  • Humans
  • Hydrocortisone*

Substances

  • Antibodies, Monoclonal, Humanized
  • pembrolizumab
  • Hydrocortisone